CompletedNCT05219487

Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration

Studying Autosomal dominant adult-onset proximal spinal muscular atrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bakri Elsheikh
Principal Investigator
Bakri Elsheikh, MBBS
Ohio State University
Intervention
Risdiplam(drug)
Enrollment
18 enrolled
Eligibility
18-70 years · All sexes
Timeline
20212025

Study locations (1)

Collaborators

Genentech, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05219487 on ClinicalTrials.gov

Other trials for Autosomal dominant adult-onset proximal spinal muscular atrophy

Additional recruiting or active studies for the same condition.

See all trials for Autosomal dominant adult-onset proximal spinal muscular atrophy

← Back to all trials